Earnings Per Share, Basic of Inhibrx, Inc. from 30 Jun 2020 to 31 Mar 2024
- Taxonomy & unit
- us-gaap: USD/shares
- Description
- The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
- Summary
-
Inhibrx, Inc. quarterly and annual Earnings Per Share, Basic in USD/shares history and change rate from 30 Jun 2020 to 31 Mar 2024.
- Inhibrx, Inc. Earnings Per Share, Basic for the quarter ending 31 Mar 2024 was -1.44, a 29% decline year-over-year.
- Inhibrx, Inc. Earnings Per Share, Basic for the twelve months ending 31 Mar 2024 was -5, a 38% decline year-over-year.
- Inhibrx, Inc. annual Earnings Per Share, Basic for 2023 was -5.12, a 41% decline from 2022.
- Inhibrx, Inc. annual Earnings Per Share, Basic for 2022 was -3.62, a 68% decline from 2021.
- Inhibrx, Inc. annual Earnings Per Share, Basic for 2021 was -2.15, a 29% increase from 2020.
- Source SEC data
- View on sec.gov
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)
Inhibrx, Inc. Quarterly Earnings Per Share, Basic (USD/shares)
| Period | TTM Value | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 2024 | -5 | -1.44 | -0.32 | -29% | 01 Jan 2024 | 31 Mar 2024 | 10-Q | 09 May 2024 | 2024 | Q1 |
| Q4 2023 | -5 | -1.82 | -0.87 | -92% | 01 Oct 2023 | 31 Dec 2023 | 10-K | 28 Feb 2024 | 2023 | Q4 |
| Q3 2023 | -4 | -1.1 | -0.2 | -22% | 01 Jul 2023 | 30 Sep 2023 | 10-Q | 09 Nov 2023 | 2023 | Q3 |
| Q2 2023 | -4 | -1.08 | -0.11 | -11% | 01 Apr 2023 | 30 Jun 2023 | 10-Q | 07 Aug 2023 | 2023 | Q2 |
| Q1 2023 | -4 | -1.12 | -0.32 | -40% | 01 Jan 2023 | 31 Mar 2023 | 10-Q | 09 May 2024 | 2024 | Q1 |
| Q4 2022 | -4 | -0.95 | -0.4 | -73% | 01 Oct 2022 | 31 Dec 2022 | 10-K | 28 Feb 2024 | 2023 | Q4 |
| Q3 2022 | -3 | -0.9 | -0.36 | -67% | 01 Jul 2022 | 30 Sep 2022 | 10-Q | 09 Nov 2023 | 2023 | Q3 |
| Q2 2022 | -3 | -0.97 | -0.42 | -76% | 01 Apr 2022 | 30 Jun 2022 | 10-Q | 07 Aug 2023 | 2023 | Q2 |
| Q1 2022 | -2 | -0.8 | -0.29 | -57% | 01 Jan 2022 | 31 Mar 2022 | 10-Q | 08 May 2023 | 2023 | Q1 |
| Q4 2021 | -2 | -0.55 | 01 Oct 2021 | 31 Dec 2021 | 10-K | 06 Mar 2023 | 2022 | Q4 | ||
| Q3 2021 | -0.54 | +0.23 | +30% | 01 Jul 2021 | 30 Sep 2021 | 10-Q | 07 Nov 2022 | 2022 | Q3 | |
| Q2 2021 | -0.55 | +0.44 | +44% | 01 Apr 2021 | 30 Jun 2021 | 10-Q | 08 Aug 2022 | 2022 | Q2 | |
| Q1 2021 | -0.51 | 01 Jan 2021 | 31 Mar 2021 | 10-Q | 09 May 2022 | 2022 | Q1 | |||
| Q3 2020 | -0.77 | 01 Jul 2020 | 30 Sep 2020 | 10-Q | 09 Nov 2021 | 2021 | Q3 | |||
| Q2 2020 | -0.99 | 01 Apr 2020 | 30 Jun 2020 | 10-Q | 09 Aug 2021 | 2021 | Q2 |
Inhibrx, Inc. Annual Earnings Per Share, Basic (USD/shares)
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2023 | -5.12 | -1.5 | -41% | 01 Jan 2023 | 31 Dec 2023 | 10-K | 28 Feb 2024 | 2023 | FY |
| 2022 | -3.62 | -1.47 | -68% | 01 Jan 2022 | 31 Dec 2022 | 10-K | 28 Feb 2024 | 2023 | FY |
| 2021 | -2.15 | +0.86 | +29% | 01 Jan 2021 | 31 Dec 2021 | 10-K | 06 Mar 2023 | 2022 | FY |
| 2020 | -3.01 | 01 Jan 2020 | 31 Dec 2020 | 10-K | 28 Feb 2022 | 2021 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.